VALERIE MCCARTNEY: Open Payments
NPI 1285275958 · GROVETOWN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 39 payments from 14 companies in 2025. Trend: 2023 $1,231 · 2024 $824 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $132 |
| PFIZER INC. | 4 | $85 |
| ABBVIE INC. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| ABIOMED | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
Products named: Kerendia, Wegovy, Ozempic, PREVNAR 20, UBRELVY, CAPLYTA, XIFAXAN, ELIQUIS.
Industry payments across GA — which companies pay providers there.
